Status:
COMPLETED
Ultrasound-guided Fascial Release Injection for Myofascial Pain Syndrome in the Upper Trapezius Muscle
Lead Sponsor:
Taipei Medical University WanFang Hospital
Conditions:
Myofascial Pain Syndrome
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Patients with myofascial pain syndrome at upper trapezius will be randomized into 2 groups, fascial injection group and subcutaneous control injection group. Pain condition pain, range of motion and f...
Detailed Description
Myofascial pain syndrome(MPS) is characterized by a trigger point with a hyperirritable nodule and taut band of muscle or fascia. MPS was usually treated by dry needling or met needing, local anesthet...
Eligibility Criteria
Inclusion
- 20-70 years old
- diagnosed as a myofascial pain syndrome at upper trapezium muscle
- trigger point
- taut band
- refer pain while taut band irritation
Exclusion
- Cognitive impairment.
- Post operation at neck and shoulder.
- Nerve compression at cervical region.
- Could not receive injection therapy, history of fainting during needling
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03867604
Start Date
June 1 2019
End Date
December 1 2022
Last Update
March 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei medical university
Taipei, Taiwan, 116